PLASMA TRIGLYCERIDES AND LIPOPROTEIN(A) - INVERSE RELATIONSHIP IN A HYPERLIPIDEMIC ITALIAN POPULATION

被引:61
作者
WERBA, JP [1 ]
SAFA, O [1 ]
GIANFRANCESCHI, G [1 ]
MICHELAGNOLI, S [1 ]
SIRTORI, CR [1 ]
FRANCESCHINI, G [1 ]
机构
[1] UNIV MILAN,INST PHARMACEUT SCI,CTR E GROSSI PAOLETTI,VIA BALZARETTI 9,I-20133 MILAN,ITALY
关键词
LIPOPROTEIN(A); TRIGLYCERIDES; HYPERTRIGLYCERIDEMIA; HYPERCHOLESTEROLEMIA;
D O I
10.1016/0021-9150(93)90117-D
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The relationship between plasma lipoprotein(a) (Lp(a)) levels and other clinical/biochemical variables was investigated in 1200 consecutive hyperlipidemic patients. Plasma Lp(a) concentrations were measured by a sandwich-ELISA method, while the patients were either on diet or diet plus lipid-lowering drugs; 38% of them had a plasma Lp(a) level > 30 mg/dl. The median plasma Lp(a) concentration and the frequency of Lp(a) > 30 mg/dl were significantly lower in individuals with severe hypertriglyceridemia vs. hypercholesterolemics (HC) or mixed hyperlipidemics (M-HLP), but similar to normolipidemic healthy controls. Patients with isolated moderate hypertriglyceridemia had Lp(a) levels intermediate between HC and M-HLP subjects. The in vitro addition of triglyceride-rich lipoproteins to normotriglyceridemic plasma did not affect the Lp(a) measurement. Plasma Lp(a) concentrations in the whole hyperlipidemic population correlated negatively with triglycerides and positively with total cholesterol, HDL-cholesterol and age, being unrelated to either body mass index or lipid-lowering treatment. In HC patients, the presence of tendon xanthomas was associated with twofold higher Lp(a) levels. These findings argue for a regulatory role of triglycerides on plasma Lp(a) levels in hyperlipidemic patients.
引用
收藏
页码:203 / 211
页数:9
相关论文
共 47 条
[21]   A DOMINANT ROLE OF LIPOPROTEIN(A) IN THE INVESTIGATION AND EVALUATION OF PARAMETERS INDICATING THE DEVELOPMENT OF CERVICAL ATHEROSCLEROSIS [J].
KOLTRINGER, P ;
JURGENS, G .
ATHEROSCLEROSIS, 1985, 58 (1-3) :187-198
[22]   LIPOPROTEIN-LP(A) AND THE RISK FOR MYOCARDIAL-INFARCTION [J].
KOSTNER, GM ;
AVOGARO, P ;
CAZZOLATO, G ;
MARTH, E ;
BITTOLOBON, G ;
QUNICI, GB .
ATHEROSCLEROSIS, 1981, 38 (1-2) :51-61
[23]   HMG COA REDUCTASE INHIBITORS LOWER LDL CHOLESTEROL WITHOUT REDUCING LP(A) LEVELS [J].
KOSTNER, GM ;
GAVISH, D ;
LEOPOLD, B ;
BOLZANO, K ;
WEINTRAUB, MS ;
BRESLOW, JL .
CIRCULATION, 1989, 80 (05) :1313-1319
[24]  
KOSTNER GM, 1991, ATHER REV, V22, P131
[25]   STUDIES ON THE ROLE OF SPECIFIC CELL-SURFACE RECEPTORS IN THE REMOVAL OF LIPOPROTEIN (A) IN MAN [J].
KREMPLER, F ;
KOSTNER, GM ;
ROSCHER, A ;
HASLAUER, F ;
BOLZANO, K ;
SANDHOFER, F .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 71 (05) :1431-1441
[26]  
KREMPLER F, 1979, BIOCHIM BIOPHYS ACTA, V575, P63, DOI 10.1016/0005-2760(79)90131-0
[27]   LIPOPROTEIN(A) - A UNIQUE RISK FACTOR FOR ATHEROTHROMBOTIC DISEASE [J].
LOSCALZO, J .
ARTERIOSCLEROSIS, 1990, 10 (05) :672-679
[28]   LACK OF EFFECT OF PROBUCOL ON SERUM LIPOPROTEIN(A) LEVELS [J].
MAEDA, S ;
OKUNO, M ;
ABE, A ;
NOMA, A .
ATHEROSCLEROSIS, 1989, 79 (2-3) :267-269
[29]  
MANCINI M, 1980, ATHER REV, V7, P157
[30]  
MCCONATHY WJ, 1990, KLIN WOCHENSCHR, V68, P117